sparfloxacin has been researched along with Skin Diseases, Infectious in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akieda, Y; Itokawa, K; Kawaguchi, H; Kawamura, H; Nakayama, I; Suzuki, T; Watanabe, T; Yamaji, E | 1 |
| Henry, DC; Lipsky, BA; Magner, DJ; McCabe, A; Miller, B; Nolan, T; Schwartz, R; Talbot, GH | 1 |
| Kashimoto, S; Kojima, T; Kouno, K; Kurobe, N; Minami, A; Nakamura, S; Nakata, K; Ohue, T; Sakaguchi, Y; Yoshida, H | 1 |
2 trial(s) available for sparfloxacin and Skin Diseases, Infectious
| Article | Year |
|---|---|
[The dose-response study of sparfloxacin against skin and soft tissue structure infections in the field of surgery].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Bacterial Infections; Connective Tissue Diseases; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Skin Diseases, Infectious | 1993 |
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Skin Diseases, Infectious; Soft Tissue Infections | 1999 |
1 other study(ies) available for sparfloxacin and Skin Diseases, Infectious
| Article | Year |
|---|---|
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Lung Diseases; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Skin Diseases, Infectious; Urinary Tract Infections | 1989 |